tiprankstipranks
Trending News
More News >
Cannara Biotech (TSE:LOVE)
:LOVE
Canadian Market

Cannara Biotech (LOVE) Financial Statements

Compare
37 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently C$173.66M. The company's EPS TTM is C$0.04; its P/E ratio is 12.73; Cannara Biotech is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 25Dec 24Dec 23Dec 22
Income Statement
Total RevenueC$ 107.32M-C$ 81.75MC$ 57.26MC$ 35.84M
Gross ProfitC$ 47.22M-C$ 29.79MC$ 27.23MC$ 17.33M
Operating IncomeC$ 22.20M-C$ 10.08MC$ 11.89MC$ 3.67M
EBITDAC$ 28.18M-C$ 15.16MC$ 15.77MC$ 9.54M
Net IncomeC$ 13.08M-C$ 6.44MC$ 6.95MC$ 2.31M
Balance Sheet
Cash & Short-Term InvestmentsC$ 14.36MC$ ―C$ 6.62MC$ 4.27MC$ 12.11M
Total AssetsC$ 168.65M-C$ 154.72MC$ 141.52MC$ 125.62M
Total DebtC$ 41.58M-C$ 48.33MC$ 45.78MC$ 48.39M
Net DebtC$ 27.22M-C$ 41.71MC$ 41.51MC$ 36.28M
Total LiabilitiesC$ 66.43M-C$ 66.77MC$ 61.78MC$ 58.88M
Stockholders' EquityC$ 102.22MC$ ―C$ 87.95MC$ 79.74MC$ 66.74M
Cash Flow
Free Cash FlowC$ 13.65M-C$ 3.21MC$ -4.44MC$ -21.55M
Operating Cash FlowC$ 20.01M-C$ 10.68MC$ 5.44MC$ -6.08M
Investing Cash FlowC$ -5.95M-C$ -5.19MC$ -9.48MC$ -15.35M
Financing Cash FlowC$ -6.32M-C$ -3.14MC$ -3.72MC$ 25.46M
Currency in CAD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS